Table 1.
Age group (months) | p | |||
---|---|---|---|---|
≤ 6.0 (n = 79) |
6.1 - 12.0 (n = 51) |
12.1 - 24.0 (n = 29) |
||
Gender (male/female)1 | 39/40 | 30/21 | 16/13 | 0.561 |
Birth weight (grams)2 | 3015 (2821; 3348) |
3020 (2793; 3364) |
3122 (2955; 3370) |
0.663 |
Birth length (cm)2 | 48.5 (47.3; 50.0) |
49.0 (48.0; 50.0) |
49.0 (47.1; 50.0) |
0.901 |
Duration of symptoms (months)2,3 | 1.0 (1.0; 2.0) |
5.0 (4.0; 7.0) |
12.0 (10.0; 18.0) |
<0.001 |
Systemic symptoms1 | 14 (17.7%) |
18 (35.3%) |
7 (24.1%) |
0.075 |
Digestive symptoms1,4 | 76 (96.2%) |
42 (82.4%) |
23 (79.3%) |
0.011 |
Cutaneous symptoms1 | 13 (16.5%) |
10 (19.6%) |
4 (13.8%) |
0.789 |
Respiratory symptoms1,4 | 9 (11.4%) |
16 (31.4%) |
6 (20.7%) |
0.019 |
1. Chi-square test
2. Median and 25th and 75th percentiles; Kruskal-Wallis test for multiple groups.
3. Dunn test for multiple comparisons for the variable "duration of symptoms"
- p < 0.05: (≤ 6.0 months) × (6.1 - 12.0 months);
- p < 0.05: (≤ 6.0 months) × (12.1 - 24.0 months);
- p < 0.05: 6.1 - 12.0 months) × (12.1 - 24.0 months);
4. Chi-square results:
Digestive symptoms: ≤ 6 months versus 6-12 months, p = 0.008; ≤ 6 months versus 12-24 months, p = 0.005; 6-12 months versus 12-24 months, p = 0.737.
Respiratory symptoms: ≤ 6 months versus 6-12 months, p = 0.005; ≤ 6 months versus 12-24 months, p = 0.304; 6-12 months versus 12-24 months, p = 0.216.